The survey on cellular and engineered tissue therapies in Europe in 2010

Tissue Engineering - Part A

Volumn 18, Issue 21-22, 2012, Pages 2268-2279

  Martin, Ivan ^a   Baldomero, Helen ^a   Bocelli Tyndall, Chiara ^b   Passweg, Jakob ^a   Saris, Daniel ^c   Tyndall, Alan ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Felix Platter Spital   (Switzerland)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3D SCAFFOLDS; ALLOGENEIC CELLS; AUTOIMMUNE DISEASE; AUTOLOGOUS CELL; CARTILAGE DEFECTS; CELL THERAPY; CELL TYPES; CELLULAR THERAPY; CHONDROCYTES; DERMAL FIBROBLASTS; ENGINEERED TISSUES; EX VIVO EXPANSION; HEMATOPOIETIC STEM CELLS; KERATINOCYTES; MUSCULOSKELETAL DISORDERS; NEUROLOGICAL DISORDERS;

CELL CULTURE; CELLS; MEDICAL PROBLEMS; SURVEYS; TISSUE;

SCAFFOLDS (BIOLOGY);

ARTICLE; CELL TRANSPLANTATION; DONOR; EUROPE; HEALTH CARE SURVEY; HUMAN; STATISTICS; TISSUE ENGINEERING;

CELL TRANSPLANTATION; EUROPE; HEALTH CARE SURVEYS; HUMANS; TISSUE DONORS; TISSUE ENGINEERING;

EID: 84868554620     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0169     Document Type: Article

References (19)

1. Gratwohl, A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). BoneMarrowTransplant 8, 197, 1991.
2. Gratwohl, A., Baldomero, H., Horisberger, B., Schmid, C., Passweg, J., and Urbano-Ispizua, A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 100, 2374, 2002.
3. Gratwohl, A., Baldomero, H., Schwendener, A., Gratwohl, M., Apperley, J., Niederwieser, D., Frauendorfer, K., and Joint Accreditation Committee of the International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; European Leukemia Net. Predictability of hematopoietic stem cell transplantation rates. Haematologica 92, 1679, 2007.
4. Tyndall, A. Successes and failures of stem cell transplantation in autoimmune diseases. Hematol Am Soc Hematol Educ Program 2011, 280, 2011.
5. Martin, I., Baldomero, H., Tyndall, A., Niederwieser, D., and Gratwohl, A. A survey on cellular and engineered tissue therapies in Europe in 2008. Tiss Eng A 16, 2419, 2010.
6. Martin, I., Baldomero, H., Bocelli-Tyndall, C., Slaper-Cortenbach, I., Passweg, J., and Tyndall, A. The survey on cellular and engineered tissue therapies in Europe in 2009. Tiss Eng A 17, 2221, 2011.
7. Richardson, J.D., Nelson, A.J., Zannettino, A.C.W., Gronthos, S., Worthley, S.G., and Psaltis, P.J. Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. Stem Cell Rev Rep 2012 [Epub ahead of print]; DOI: 10.1007/s12015-012-9366-7.
8. Peterson, L., Vasiliadis, H.S., Brittberg, M., and Lindahl, A. Autologous chondrocyte implantation: a long-term followup. Am J Sports Med 38, 1117, 2010.
9. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., and Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331, 889, 1994
10. Bekkers, J.E., Inklaar, M., and Saris, D.B. Treatment selection in articular cartilage lesions of the knee: a systematic review. Am J Sports Med 37, 148S, 2009.
11. de Windt, T.S., Bekkers, J.E., Creemers, L.B., Dhert, W.J., and Saris, D.B. Patient profiling in cartilage regeneration: prognostic factors determining success of treatment for cartilage defects. Am J Sports Med 37, 58S, 2009.
12. Vanlauwe, J., Saris, D.B., Victor, J., Almqvist, K.F., Bellemans, J., and Luyten, F.P. Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med 39, 2566, 2011.
13. Acharya, C., Adesida, A., Zajac, P., Mumme, M., Jakob, M., Riesle, J., Martin, I., and Barbero, A. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol 227, 88, 2011.
14. Gomoll, A.H., Filardo, G., de Girolamo, L., Espregueira-Mendes, J., Marcacci, M., Rodkey, W.G., Steadman, J.R., Zaffagnini, S., and Kon, E. Surgical treatment for early osteoarthritis. Part I: cartilage repair procedures. Knee Surg Sports Traumatol Arthrosc 20, 450, 2012
15. Gomoll, A.H., Filardo, G., Almqvist, F.K., Bugbee, W.D., Jelic, M., Monllau, J.C., Puddu, G., Rodkey, W.G., Verdonk, P., Verdonk, R., Zaffagnini, S., and Marcacci, M. Surgical treatment for early osteoarthritis. Part II: allografts and concurrent procedures. Knee Surg Sports Traumatol Arthrosc 20, 468, 2012.
16. Martin, I., Smith, T., and Wendt, D. A roadmap for the bioreactor-based translation of tissue engineering strategies into clinical products. Trends Biotech 27, 495, 2009.
17. Saris, D.B., Buma, P., and Bulstra, S.K. Advies van de Nederlandse Orthopaedische Vereniging; Chirurgische behandelingen van kraakbeendefecten in de knie. Available at www.orthopeden.org, 2011.
18. Behrens, P., Bosch, U., Bruns, J., et al. [Indications and implementation of recommendations of the working group "Tissue Regeneration and Tissue Substitutes" for autologous chondrocyte transplantation (ACT)]. Z Orthop Ihre Grenzgeb 142, 529, 2004.
19. Vanlauwe, J., Almqvist, F., Bellemans, J., Huskin, J.P., Verdonk, R., and Victor, J. Repair of symptomatic cartilage lesions of the knee: the place of autologous chondrocyte implantation. Acta Orthop Belg 73, 145, 2007.